Cue Health Inc.
HLTHQ
$0.00
$0.000.00%
| Weiss Ratings | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.05 | |||
| Price History | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.30 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Aug 12, 2024 | |||
| 52-Week High Price (Date) | Mar 13, 2024 | |||
| Valuation | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 159.00 | |||
| Enterprise Value | 4.08M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -2.44 | |||
| Earnings Per Share Growth | 85.99% | |||
| Price/Earnings To Growth | 0.00 | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 0.06 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -0.02 | |||
| Enterprise Value/EBIT | -0.02 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 154.81M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (858) 412-8151 | |||
| Address | 4980 Carroll Canyon Road San Diego, CA 92121 | |||
| Website | www.cuehealth.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -371.84% | |||
| Profit Margin | -526.48% | |||
| Management Effectiveness | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -31.88% | |||
| Return on Equity | -- | |||
| Income Statement | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 70.94M | |||
| Total Revenue (TTM) | 70.94M | |||
| Revenue Per Share | $0.46 | |||
| Gross Profit (TTM) | -194.78M | |||
| EBITDA (TTM) | -219.20M | |||
| EBIT (TTM) | -263.78M | |||
| Net Income (TTM) | -373.46M | |||
| Net Income Avl. to Common (TTM) | -373.46M | |||
| Total Revenue Growth (Q YOY) | -87.19% | |||
| Earnings Growth (Q YOY) | -371.12% | |||
| EPS Diluted (TTM) | -2.44 | |||
| EPS Diluted Growth (Q YOY) | -352.48% | |||
| Balance Sheet | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 80.89M | |||
| Cash Per Share (Q) | $0.52 | |||
| Total Current Assets (Q) | 110.36M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 250.25M | |||
| Current Ratio (Q) | 2.539 | |||
| Book Value Per Share (Q) | $1.61 | |||
| Total Assets (Q) | 339.79M | |||
| Total Current Liabilities (Q) | 43.47M | |||
| Total Debt (Q) | 47.94M | |||
| Total Liabilities (Q) | 89.54M | |||
| Total Common Equity (Q) | 250.25M | |||
| Cash Flow | HLTHQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -19.80M | |||
| Cash from Financing (TTM) | -3.03M | |||
| Net Change in Cash (TTM) | -160.64M | |||
| Levered Free Cash Flow (TTM) | -4.15M | |||
| Cash from Operations (TTM) | -137.81M | |||
